Germany Female infertility Market

Germany Female infertility Market Size, Share & Trends Analysis Report, By Diagnosis (Ovulation Testing, Hysterosalpingography (HSG), Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others (Laparoscopy)), By End-User (Hospitals and Clinics, Homecare, and Pathology and Diagnostic Centers), and Forecast, 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jan 2020 | Report Code: OMR2020561 | Category : Medical Devices | Delivery Format: /

Germany female infertility market is expected to witness a significant growth rate during the forecast period. The country has a major market share for the female infertility market in Europe due to increasing cases of infertility. As per CIA the mean age of mother at the time of first birth is 29.4 years. It has increased by 2 years in 2016 as compared to 2013. In 2017, out of the total population, 41 million are female and 39% of the female is the age of 25-54 years, age in which female population mostly faces the problems of infertility. Due to the high proportion of females in this age criteria, the problem of infertility is expected to be witnessed in the region during the forecast period.

Moreover, the subsidization of IVF treatments in Germany further contributes to the growth of the market. According to the European Society of Human Reproduction and Embryology (ESHRE) in 2017, National policy in Germany reimburses 50% of IVF/ICSI costs for up to three cycles which in turn, is expected to drive the IVF industry and hence female infertility treatment market.

Germany female infertility market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center.

Some of the major players operating in Germany female infertility market include Abbott Laboratories, Inc., Merck KGaA, Cipla Ltd., and others. These players adopt various organic and inorganic growth strategies such as merger and acquisition and product launch to strengthen their presence in Germany market.

Research Methodology

The market study of Germany female infertility market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for existing companies and new entrants into the market, potential investors and venture capitalists, government organizations, and various end-user industries for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions. 

Market Segmentation:

  1. Germany Female infertility  Market Research and Analysis by Diagnosis
  2. Germany Female infertility  Market Research and Analysis by Treatment
  3. Germany Female infertility  Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of Germany female infertility market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting Germany female infertility market.
  • Insights about market determinants which are stimulating Germany female infertility market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools 

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report 

2.2. Analyst Insight& Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Germany Female Infertility Diagnosis And Treatment Market by Treatment

5.1.1. Drugs 

5.1.2. Surgery

5.1.3. Intrauterine Insemination (IUI)

5.1.4. Assisted Reproductive Technology (ART)

5.2. Germany Female Infertility Diagnosis And Treatment Diagnosis and Treatment Market by Diagnosis

5.2.1. Ovulation Testing 

5.2.2. Hysterosalpingography (HSG) 

5.2.3. Hysteroscopy

5.2.4. Imaging Testing

5.2.5. Ovarian Reserve Testing

5.2.6. Hormonal Level Testing

5.2.7. Genetic Testing

5.2.8. Others (Laparoscopy)

5.3. Germany Female Infertility Diagnosis And Treatment Market by End-User

5.3.1. Hospitals and Clinics

5.3.2. Homecare

5.3.3. Pathology and Diagnostic Centers

6. Company Profiles

6.1. Bayer AG

6.2. Merck KGaA

6.3. Pfizer

6.4. Church & Dwight Co., Inc.

6.5. Vitrolife

6.6. Cook Medical, Inc.

6.7. GlaxoSmithKline Plc.

6.8. Merck KGaA

6.9. Esco Group

1. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2018-2025 ($ MILLION)

2. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TEATMENT, 2018-2025 ($ MILLION)

3. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)



1. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2018 VS 2025 (%)

2. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)

3. GERMANY FEMALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY END-USER, 2018 VS 2025 (%)